Literature DB >> 28334820

High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington's disease CAG knock-in mice across multiple genetic backgrounds.

Seth A Ament1,2, Jocelynn R Pearl1,3, Andrea Grindeland4, Jason St Claire5, John C Earls1,6, Marina Kovalenko5, Tammy Gillis5, Jayalakshmi Mysore5, James F Gusella5, Jong-Min Lee5, Seung Kwak7, David Howland7, Min Young Lee1, David Baxter1, Kelsey Scherler1, Kai Wang1, Donald Geman8, Jeffrey B Carroll9, Marcy E MacDonald5, George Carlson4, Vanessa C Wheeler5, Nathan D Price1, Leroy E Hood1.   

Abstract

Huntington's disease is a dominantly inherited neurodegenerative disease caused by the expansion of a CAG repeat in the HTT gene. In addition to the length of the CAG expansion, factors such as genetic background have been shown to contribute to the age at onset of neurological symptoms. A central challenge in understanding the disease progression that leads from the HD mutation to massive cell death in the striatum is the ability to characterize the subtle and early functional consequences of the CAG expansion longitudinally. We used dense time course sampling between 4 and 20 postnatal weeks to characterize early transcriptomic, molecular and cellular phenotypes in the striatum of six distinct knock-in mouse models of the HD mutation. We studied the effects of the HttQ111 allele on the C57BL/6J, CD-1, FVB/NCr1, and 129S2/SvPasCrl genetic backgrounds, and of two additional alleles, HttQ92 and HttQ50, on the C57BL/6J background. We describe the emergence of a transcriptomic signature in HttQ111/+  mice involving hundreds of differentially expressed genes and changes in diverse molecular pathways. We also show that this time course spanned the onset of mutant huntingtin nuclear localization phenotypes and somatic CAG-length instability in the striatum. Genetic background strongly influenced the magnitude and age at onset of these effects. This work provides a foundation for understanding the earliest transcriptional and molecular changes contributing to HD pathogenesis.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28334820      PMCID: PMC6075528          DOI: 10.1093/hmg/ddx006

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  44 in total

Review 1.  Neuroinflammation in Huntington's disease.

Authors:  Thomas Möller
Journal:  J Neural Transm (Vienna)       Date:  2010-06-10       Impact factor: 3.575

2.  Neurodegeneration. A glutamine-rich trail leads to transcription factors.

Authors:  Richard N Freiman; Robert Tjian
Journal:  Science       Date:  2002-06-21       Impact factor: 47.728

3.  In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets.

Authors:  Weiguo Zhai; Hyunkyung Jeong; Libin Cui; Dimitri Krainc; Robert Tjian
Journal:  Cell       Date:  2005-12-29       Impact factor: 41.582

4.  Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.

Authors:  A Giralt; M Puigdellívol; O Carretón; P Paoletti; J Valero; A Parra-Damas; C A Saura; J Alberch; S Ginés
Journal:  Hum Mol Genet       Date:  2011-11-24       Impact factor: 6.150

Review 5.  Striatal specificity of gene expression dysregulation in Huntington's disease.

Authors:  Elizabeth A Thomas
Journal:  J Neurosci Res       Date:  2006-11-01       Impact factor: 4.164

Review 6.  Molecular mechanisms and potential therapeutical targets in Huntington's disease.

Authors:  Chiara Zuccato; Marta Valenza; Elena Cattaneo
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

7.  Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease.

Authors: 
Journal:  Cell       Date:  2015-07-30       Impact factor: 41.582

8.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

9.  Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice.

Authors:  Marina Kovalenko; Ella Dragileva; Jason St Claire; Tammy Gillis; Jolene R Guide; Jaclyn New; Hualing Dong; Raju Kucherlapati; Melanie H Kucherlapati; Michelle E Ehrlich; Jong-Min Lee; Vanessa C Wheeler
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

10.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes.

Authors:  Anne E Carpenter; Thouis R Jones; Michael R Lamprecht; Colin Clarke; In Han Kang; Ola Friman; David A Guertin; Joo Han Chang; Robert A Lindquist; Jason Moffat; Polina Golland; David M Sabatini
Journal:  Genome Biol       Date:  2006-10-31       Impact factor: 13.583

View more
  17 in total

Review 1.  Taking Systems Medicine to Heart.

Authors:  Kalliopi Trachana; Rhishikesh Bargaje; Gustavo Glusman; Nathan D Price; Sui Huang; Leroy E Hood
Journal:  Circ Res       Date:  2018-04-27       Impact factor: 17.367

Review 2.  Modifiers of CAG/CTG Repeat Instability: Insights from Mammalian Models.

Authors:  Vanessa C Wheeler; Vincent Dion
Journal:  J Huntingtons Dis       Date:  2021

Review 3.  Progress in developing transgenic monkey model for Huntington's disease.

Authors:  Brooke R Snyder; Anthony W S Chan
Journal:  J Neural Transm (Vienna)       Date:  2017-11-10       Impact factor: 3.575

Review 4.  On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability.

Authors:  Alexandra N Khristich; Sergei M Mirkin
Journal:  J Biol Chem       Date:  2020-02-14       Impact factor: 5.157

5.  Striatal Projection Neurons Require Huntingtin for Synaptic Connectivity and Survival.

Authors:  Caley J Burrus; Spencer U McKinstry; Namsoo Kim; M Ilcim Ozlu; Aditya V Santoki; Francia Y Fang; Annie Ma; Yonca B Karadeniz; Atesh K Worthington; Ioannis Dragatsis; Scott Zeitlin; Henry H Yin; Cagla Eroglu
Journal:  Cell Rep       Date:  2020-01-21       Impact factor: 9.423

6.  High-Throughput Functional Analysis Distinguishes Pathogenic, Nonpathogenic, and Compensatory Transcriptional Changes in Neurodegeneration.

Authors:  Ismael Al-Ramahi; Boxun Lu; Simone Di Paola; Kaifang Pang; Maria de Haro; Ivana Peluso; Tatiana Gallego-Flores; Nazish T Malik; Kelly Erikson; Benjamin A Bleiberg; Matthew Avalos; George Fan; Laura Elizabeth Rivers; Andrew M Laitman; Javier R Diaz-García; Marc Hild; James Palacino; Zhandong Liu; Diego L Medina; Juan Botas
Journal:  Cell Syst       Date:  2018-06-20       Impact factor: 10.304

Review 7.  Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models.

Authors:  Jordi Creus-Muncunill; Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

8.  Single-Nucleus RNA-Seq Reveals Dysregulation of Striatal Cell Identity Due to Huntington's Disease Mutations.

Authors:  Sonia Malaiya; Marcia Cortes-Gutierrez; Brian R Herb; Sydney R Coffey; Samuel R W Legg; Jeffrey P Cantle; Carlo Colantuoni; Jeffrey B Carroll; Seth A Ament
Journal:  J Neurosci       Date:  2021-05-19       Impact factor: 6.167

Review 9.  Epigenetic regulation in Huntington's disease.

Authors:  Jae Wook Hyeon; Albert H Kim; Hiroko Yano
Journal:  Neurochem Int       Date:  2021-05-24       Impact factor: 4.297

10.  HttQ111/+ Huntington's Disease Knock-in Mice Exhibit Brain Region-Specific Morphological Changes and Synaptic Dysfunction.

Authors:  Marina Kovalenko; Austen Milnerwood; James Giordano; Jason St Claire; Jolene R Guide; Mary Stromberg; Tammy Gillis; Ellen Sapp; Marian DiFiglia; Marcy E MacDonald; Jeffrey B Carroll; Jong-Min Lee; Susan Tappan; Lynn Raymond; Vanessa C Wheeler
Journal:  J Huntingtons Dis       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.